TNF and inflammatory bowel disease: Biologic treatments, particularly anti-TNF-α agents are the most effective medications for moderate-severe forms of IBD, however despite their efficacy they have a considerable risk of serious adverse events, are expensive, and have a relatively high rate of non-response and LOR, particularly in certain patient groups.